Research and Clinical Trials

Title  
PBMTC J13161: A Pediatric Blood and Marrow Transplant Consortium (PBMTC) multi-center Phase II Pilot Trial of Myeloablative Conditioning and Transplantation of Partially HLA-mismatched T cell replete Bone Marrow with post-transplantation cyclophosphamide
Brief Description  
To estimate the incidence of non-relapse mortality at 180 days following myeloablative haploidentical BMT for children and young adults with high risk hematologic malignancies.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Other Hematopoietic
Status  
OPEN
Start Date  
03/31/2017
IRB Number  
00019890
Principal Investigator  
Huo, Jeffrey
Contact Name  
Tracy L Fukes

For More Information, Contact  Tracy  L, Fukes
Phone:  980-442-2310 Fax:    
Email:  tracy.fukes@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close